MarketResearchReports.Biz announces addition of new report “Frontier Pharma - Rheumatoid Arthritis: Identifying and Commercializing First-in-Class Innovation” to its database

Albany, NY -- (SBWire) -- 10/16/2013 --Frontier Pharma - Rheumatoid Arthritis: Identifying and Commercializing First-in-Class Innovation

A new pharmaceutical report – “Frontier Pharma – Identifying and Commercializing first-in-class Innovation”. This highly competitive market is saturated with multiple targeted monoclonal Antibody (mAb) therapies and small molecules, yet more of these treatments are expected to enter the market over the next few years. Despite this, the current developmental pipeline is highly innovative beyond these me-too products and incremental innovations and promises a number of first-in-class products across all stages. These new developments are driven by improvements in the understanding of signaling pathways and underlying disease mechanisms of Rheumatoid Arthritis (RA).

To check out the complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/frontier-pharma-rheumatoid-arthritis-identifying-and-commercializing-first-in-class-innovation

These highly innovative products are expected to increase the diversity of available products, in terms of mechanism of action over the coming decade and are likely to have a significant impact on the dynamics of the clinical and commercial landscape. The market is also characterized by high activity in licensing and co-development deals. In particular, there is sustained commercial interest in pipeline biologic therapies with a range of molecular targets. There is also considerable interest in small molecule inhibitors of intracellular kinases despite their clinical performances not being as well established as biologics or mAbs.

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/176667

Scope

The report analyzes the RA pipeline and strategic alliance landscape with particular emphasis on first-in-class programs.

The report provides:

- A brief introduction to RA, including symptoms, pathophysiology, and an overview of the pharmacotherapy
- Highlights of the changing molecular target landscape between marketed and pipeline products with particular focus on innovation
- A comprehensive review of first-in-class pipeline therapies; the pipeline is analyzed by Phase distribution, molecule type, molecular target, and administration route
- Identification and assessment of first-in-class molecular targets highlighting early-stage programs with clinical utility that has yet to be evaluated, as well as an in-depth literature review of novel molecular targets
- Assessment of the licensing and co-development deals for RA therapeutics

To buy the copy of this report, visit: http://www.marketresearchreports.biz/analysis/176667

Reasons to Buy

The report will assist business development strategies of companies who wish to develop RA therapies with improved benefits to existing treatments. In addition, this report will be of interest to companies seeking to expand pipeline portfolios through licensing agreements and co-development deals allowing them to:

- Understand the overall focal shifts in therapeutic molecular targets of RA treatments
- Identify first-in-class product development and understand the therapeutic and commercial prospects of first-in-class developmental programs based on available animal model data
- Assess the value of products benchmarked against licensed and co-developed therapeutic programs
- Spot first-in-class programs that are potentially available for licensing and co-development deals

Table of Contents

1 Table of Contents 5
2 Introduction 9
3 Rheumatoid Arthritis 12
4 Overview of Pipeline Products for Rheumatoid Arthritis 24
5 Target and Pipeline Program Evaluation 38
6 Deals and Strategic Consolidations 74
7 Appendix 99

Latest Reports:
Enterprise Video Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/enterprise-video-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

The rapid globalization has increased the need for effective communication systems. Companies have been experiencing an escalating need of video interfaces for communication purposes, owing to its ability to increase outreach and productivity. Thus, enterprise video services are used on a large extent in these areas. The market is segmented on the basis of hardware, such as video recording and storage devices, video casting devices, video management and control and video distribution. On the basis of software the market is classified as, video content management, video analytics software, video security software, video collaboration software, video asset management and video encoding and decoding software.

Increasing BYOD culture and adoption of cloud technologies are the key driving forces for this market. Moreover, with the introduction of newer technologies, there has been innovation in advanced video platforms. Moreover, enterprise video service helps reduce overall capital expenditure and improves flexibility in remote conditions. As a result, enterprise video market is expected to grow rapidly over the forecast period.

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/175716

Similarly, on the basis of services market is segmented as consulting, system integration, managed services and other services. Further, the market is also segmented on the basis of delivery modes, such as web conferencing, video streaming, webcasting and video conferencing. Moreover, the enterprise video market is classified into different industry verticals which include banking and financial services (BFSI), academia and government, consumer goods and retail, media and entertainment, healthcare, manufacturing, transportation and logistics, and telecom and IT. The market is further segmented on the basis of applications, such as corporate communication, knowledge sharing and management and learning and development among others.

Gonorrhea Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/gonorrhea-diagnostic-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Gonorrhea is a contagious sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae. The disease can also pass on to a new born through infected mother during parturition. This disease can affect both men and women. The bacterium grows in warm and moist areas of uterus, reproductive tract, fallopian tubes and urethra. In addition, the bacterium can also grow in the throat, mouth and anus. According to Center for Disease Control (CDC), in 2010 the total number of people suffering from gonorrhea was estimated to be around 3 lacs in the U.S.

Diagnostic tests for gonorrhea include diagnostic imaging, flow cytometry, gel microdroplets, chromatography, artificial intelligence, liposomes, Differential Light Scattering (DLS), molecular diagnostics and monoclonal antibodies test. Amongst these tests, molecular diagnostic is most preferred test. Molecular test include Nucleic Acid Amplification Tests (NAAT) which is highly sensitive test for urine and swab test. It is FDA approved for the diagnosis of gonorrhea.

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/174479

Change in lifestyle has resulted in multiple sex and sex partner. It has been observed that three out of five people suffer from chlamydia every year and it is expected to rise drastically. It has been reported that in 2011, gonorrhea increased by 61% globally. This severe growth of gonorrhea patients worldwide would augment the growth of this market. Gonorrhea increases the risk of HIV infection and this is raising serious concern amongst governments of various nations. According to CDC, Federal Domestic Assistance grants a project under section 318c. This project aimed for the development and implementation of prevention and control program for this disease. This increasing concern of government would trigger the growth of this market. In addition, rise in disposable income of population would also increase the growth of this market.

About MarketResearchReports.Biz
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
Blog: http://mrrfocuseconomics.blogspot.com/